Pitt Shield

Focused ultrasound gene delivery for the treatment of neurological disorders.

Authors: Kofoed RH, Aubert I

The transformative potential of gene therapy has been demonstrated in humans. However, there is an unmet need for non-invasive targeted gene delivery and regulation in the treatment of brain disorders. Transcranial focused ultrasound (FUS) has gained tremendous momentum to address these challenges. FUS non-invasively modulates brain cells and their environment, and is a powerful tool to facilitate gene delivery across the blood-brain barrier (BBB) with millimeter precision and promptly regulate transgene expression. This review highlights technical aspects of FUS-mediated gene therapies for the central nervous system (CNS) and lessons learned from discoveries in other organs. Understanding the possibilities and remaining obstacles of FUS-mediated gene therapy will be necessary to harness remarkable technologies and create life-changing treatments for neurological disorders.

Introduction

Purpose Drug delivery with BBB opening
Study Objective To evaluate focused ultrasound as a method for delivering therapeutic genes to the brain for treatment of neurological disorders.

Outcomes and Safety

Summary of Outcomes Insufficient information in the provided text (only the paper title) to determine the main biological or behavioral effects or to list which focused ultrasound parameters were found successful.
Safety-related matter No safety or adverse effects are mentioned in the provided text.

Brain Region

Visualization unavailable

Ultrasound Parameters

Focal Characteristics Focal depth: None; Focal length: None; Aperture size: None

We are open to feedback. If you see a mistake or have a suggestion, please contact us.

← Back to Search